The Uromigos artwork

Medicine · The Uromigos

The Uromigos

by The Uromigos

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Latest episodes

Showing 20 · updated from the feed

Uromigos Live 2026 – T Cell Engagers in RCC: Have We Finally Turned a Corner?

The final session of this year’s meeting discusses exciting T cell engager and CAR-T data from ESMO 2026. Are these approaches finally ready for prime time in mRCC?  

Nov 15
25 min

Uromigos Live 2026 – Are Doublets the New Standard of Care Throughout the RCC Continuum?

Doublet therapy has produced positive results in the adjuvant and refractory RCC settings. Are they the standard of care and what is the role of monotherapy for individua

Nov 15
41 min

Uromigos Live 2026 – Triplet Therapy in mRCC: What Went Wrong?

Recent attempts to build on the IO-doublet backbone in front-line clear cell RCC therapy have failed including LITESPARK-012. The panel discusses issues that have impacte

Nov 15
45 min

Uromigos Live 2026 – Sequencing of Therapy Across the Continuum of Advanced Prostate Cancer

Several third agents added to the ADT/ARPI backbone in mHSPC have emerged in the last year including radioligands and PARP inhibitors. Navigating application to individua

Nov 14
49 min

Uromigos Live 2026 – High-risk Localized Prostate Cancer

Several phase 3 trials in high-risk localized prostate cancer have reported this year including PROTEUS and DASL. The panel debates if and how these will impact treatment

Nov 14
48 min

Uromigos Live 2026 – MIBC: The Evolution of Antibody Drug Conjugates (ADCs) in Bladder Cancer

ADCs have become a mainstay of systemic therapy in bladder cancer. Where are we headed next? The panel discusses issues around target, payload and sequencing.

Nov 14
43 min

Uromigos Live 2026 – MIBC: What is the necessity of bladder-directed therapy?

The emergence of highly active systemic therapy in the MIBC setting has challenged the notion that all patients need cystectomy or chemoradiation. Our live panel debates

Nov 14
20 min

Uromigos Live 2026 – MIBC: Does ctDNA and/or utDNA Have a Role?

The panel discusses emerging data on if and how ctDNA and urinary tumor DNA (utDNA) can be incorporated into prognostication and treatment decisions.

Nov 14
29 min

Uromigos Live 2026 – MIBC: How Does VOLGA Change the Landscape?

The VOLGA trial was presented at ESMO 2026 and challenged the necessity of adjuvant therapy in MIBC. The panel discusses how these critical data impact the landscape.

Nov 14
44 min

Uromigos Live 2026 – MIBC: What is the Role of Platinum-based Chemotherapy and/or Immune Therapy?

This kickoff session at this year’s live meeting looks at whether chemotherapy and immune therapy outside of EVP have a role in MIBC.

Nov 14
27 min

Episode 530: ESMO 2026 Review

Silke, Brian and Tom review exciting ESMO 2026 data in GU Oncology and more.

Nov 2
1 h 00 min

Episode 529: ESMO 2026 - LITESPARK-011 Updated Results including Overall Survival

Danny Heng joins the show to discuss his ESMO 2026 presentation of LITESPARK-011 and the OS data. Published today in Annals of Oncology!

Oct 25
30 min

Episode 528: ESMO 2026 - LITESPARK 012

Martin Voss takes on the role of Host and interviews Brian and Tom about this phase 3 study of triplets in metastatic ccRCC. Published today in Annals of Oncology!

Oct 25
44 min

Episode 527: ESMO 2026 - DASL-HiCaP Adding Darolutamide to ADT and XRT in High-risk Localized Prostate Cancer

Chris Sweeney discusses this ANZUP trial which adds more phase 3 data to the high risk prostate cancer space.

Oct 24
38 min

Episode 526: ESMO 2026 - The VOLGA trial in MIBC

Michiel Van Der Heijden joins us after his ESMO discussion and Tom's presentation to discuss how these critical data reshape the MIBC landscape.

Oct 24
37 min

Episode 525: ESMO 2026 - PEACE-1 and CAPItello-281

Karim Fizazi joins Brian and Tom to discuss two ESMO 2026 presentations of long-term follow up data in mHSPC

Oct 24
46 min

Episode 524: ESMO 2026 - JNJ-6143, a Novel RIPTAC in mCRPC

Ben Garmezy discusses the phase 1 data of a novel mechanism in CRPC. This RIPTAC (Regulated Induced Proximity TargetingChimera) Molecule uses AR to enter the prostate can

Oct 24
16 min

Episode 523: ESMO 2026: ctDNA Kinetics from Neoadjuvant EVP in MIBC

Jon Chatzkel joins us after his ESMO 2026 presentation to discuss ctDNA results from the KEYNOTE 905 trial.

Oct 23
35 min

Episode 522: ESMO 2026 - KEYNOTE-905 Analysis of Neoadjuvant EVP or Pembro Monotherapy in Cis-ineligible MIBC

Anders Ullen joins the show after his EMSO 2026 presentation looking at KN-905 for the period in which Cis-ineligible MIBC patients were randomized to immediate cystectom

Oct 23
24 min

Episode 521: ESMO 2026 - Reconciling Discrepant Results of Neoadjuvant Chemotherapy + IO in MIBC

Rob Jones joins the show to discuss two phase 3 trials from ESMO 2026 which did not show benefit from chemotherapy + IO vs chemo in MIBC. We discuss the wider implication

Oct 23
32 min

Chart trend

Position in the Medicine chart (US), last 90 days.

#66
all-time peak
6
days in the top 100 since Feb 2025

Chart positions

Where The Uromigos ranks today in each Apple Podcasts chart (US, Nov 16, 2026).

#66 ▲ 29 Medicine US

What listeners say

A curated, balanced selection of Apple Podcasts reviews.

The Uromigos keep patients and doctors informed with the very latest studies and research in urogenital cancer. I appreciate their hopeful, upbeat and revealing interviews with cutting edge researchers.

Tea Green · Oct 2025

Drs. Powles and Rini are some of the most eminent current leaders in GU oncology. In this podcast, they discuss recent key studies in the field and really break down the key questions clinicians and patients want to know — are they clinically significant, will they change practice, and what are the next steps? Also, there are a lot of cheesy jokes which this humble listener somehow enjoys.

Attentive listener 12345 · Feb 2024

This is a fantastic podcast! Great insight with provocative discussions (while keeping it lighthearted at the same time).... Thank you guys. Keep them coming....

Jacky4911 · Jun 2021

This is a great series with insightful analysis of the data from recent clinical trials.

Yulia44 · Mar 2020

We strive to present a balanced view by showing a diverse range of reviews from Apple Podcasts.

More podcasts like The Uromigos

Popular shows in Medicine, for your next listen.

Browse charts by category

Daily updated Apple Podcasts rankings for the United States.

About The Uromigos on Reason.fm

Here you find the Apple Podcasts chart positions of The Uromigos, its latest episodes to listen to directly, and reviews from listeners. Rankings are updated daily for the United States.

Contact

Questions or issues? Reach us at hello@reason.fm

0:000:00